Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2000 1
2001 1
2003 1
2004 1
2006 1
2008 1
2009 1
2010 3
2012 3
2013 2
2014 3
2015 4
2016 3
2017 2
2018 3
2019 2
2020 1
2021 3
2022 2
2023 3
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Dissecting Airborne Allergens.
Torres-Borrego J, Sánchez-Solís M. Torres-Borrego J, et al. J Clin Med. 2023 Sep 8;12(18):5856. doi: 10.3390/jcm12185856. J Clin Med. 2023. PMID: 37762797 Free PMC article. Review.
The influence of microorganisms in allergic diseases.
Tortajada-Girbés M, Torres-Borrego J. Tortajada-Girbés M, et al. Among authors: torres borrego j. Allergol Immunopathol (Madr). 2017 Nov-Dec;45(6):519-520. doi: 10.1016/j.aller.2017.10.001. Allergol Immunopathol (Madr). 2017. PMID: 29110881 No abstract available.
Omalizumab: just what we needed.
Torres-Borrego J. Torres-Borrego J. Allergol Immunopathol (Madr). 2014 Jan-Feb;42(1):1-2. doi: 10.1016/j.aller.2014.01.001. Allergol Immunopathol (Madr). 2014. PMID: 24529608 No abstract available.
Efficacy and effectiveness of omalizumab in the treatment of childhood asthma.
Tortajada-Girbés M, Bousquet R, Bosque M, Carrera Martínez JJ, Ibáñez MD, Moreira A, Nieto A, Plaza AM, Rivas C, Requena G, Sánchez-Solis M, Tabar A, Torres-Borrego J, Zapatero L. Tortajada-Girbés M, et al. Among authors: torres borrego j. Expert Rev Respir Med. 2018 Sep;12(9):745-754. doi: 10.1080/17476348.2018.1507740. Epub 2018 Aug 28. Expert Rev Respir Med. 2018. PMID: 30141696 Review.
[Cross reactivity between fish and shellfish].
Torres Borrego J, Martínez Cuevas JF, Tejero García J. Torres Borrego J, et al. Allergol Immunopathol (Madr). 2003 May-Jun;31(3):146-51. doi: 10.1016/s0301-0546(03)79282-9. Allergol Immunopathol (Madr). 2003. PMID: 12783765 Review. Spanish.
Cost-effectiveness of omalizumab for the treatment of severe pediatric allergic asthma-Results of a real-life study in Spain.
Nieto-Cid M, Garriga-Baraut T, Plaza-Martín AM, Tortajada-Girbés M, Torres-Borrego J, Lozano-Blasco J, Moreno-Galarraga L, Del Mar Folqué-Giménez M, Bosque-García M, Gaboli M, López-Neyra A, Rivas-Juesas C, Caballero-Rabasco MA, Freixa-Benavente A, Valdesoiro-Navarrete L, de Mir-Messa I, Ballester-Asensio E, Penín-Antón M, Romero-García R, Navarro-Morón J, Valenzuela-Soria A, Sánchez-Mateos M, Batlles-Garrido J, Sanz-Santiago V, de Atauri ÁG, Andrés-Martín A, Campos-Alonso E, Gómez-Pastrana D, Vázquez-Rodríguez E, Martínez-Pardo L, Del Río-Camacho G, Mazón-Ramos Á, Nieto-García A. Nieto-Cid M, et al. Among authors: torres borrego j. Pediatr Allergy Immunol. 2023 Apr;34(4):e13942. doi: 10.1111/pai.13942. Pediatr Allergy Immunol. 2023. PMID: 37102393
Sublingual immunotherapy: factors influencing adherence.
Bernaola G, Corzo JL, Domínguez-Ortega J, Lucas C, Ojeda I, Torres-Borrego J; ARIAL Group. Bernaola G, et al. Among authors: torres borrego j. J Investig Allergol Clin Immunol. 2012;22(6):458-9. J Investig Allergol Clin Immunol. 2012. PMID: 23101200 Free article. No abstract available.
38 results